Table 1.

Subject Baseline Characteristics (Safety Population)

	Study 1 FP/S 100/50 μg (N = 66)	Study 2 FP/S 250/50 μg (N = 66)	Study 3 FP/S 500/50 μg (N = 66)
Age, n (%)
Females	29 (43.9)	36 (54.5)	42 (63.6)
Males	37 (56.1)	30 (45.5)	24 (36.4)
Age, mean (range), years	33.8 (19–53)	37.7 (18–55)	35.7 (19–53)
Race, n (%)
White	40 (60.6)	51 (77.3)	47 (71.2)
Black or African American	23 (34.8)	14 (21.2)	17 (25.8)
Other	3 (4.5)	1 (1.5)	2 (3.0)
BMI, mean ± SD, kg/m2	26.3 ± 2.7	26.3 ± (3.3)	25.8 ± 2.5
Tobacco history, n (%)
Never used	54 (81.8)	57 (86.4)	58 (87.9)
Past use of tobacco	12 (18.2)	9 (13.6)	8 (12.1)

BMI, body mass index; FP/S, fluticasone propionate/salmeterol; SD, standard deviation.